Cited by 1,345BRCA gene mutations in cancerCancer Genomics and DiagnosticsGenomics and Rare Diseases

The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.

Germline Mutations in Predisposition Genes in Pediatric Cancer

Open access

Zhang, Jinghui, Walsh, Michael F., Wu, Gang, Edmonson, Michael N., Gruber, Tanja A., Easton, John, Hedges, Dale, Ma, Xiaotu, Zhou, Xin, Yergeau, Donald A., Wilkinson, Mark R., Vadodaria, Bhavin, Chen, Xiang, McGee, Rose B., Hines-Dowell, Stacy, Nuccio, Regina, Quinn, Emily, Shurtleff, Sheila A., Rusch, Michael, Patel, Aman, Becksfort, Jared B., Wang, Shuoguo, Weaver, Meaghann S., Ding, Li, Mardis, Elaine R., Wilson, Richard K., Gajjar, Amar, Ellison, David W., Pappo, Alberto S., Pui, Ching-Hon, Nichols, Kim E., Downing, James R.·2015·New England Journal of Medicine

DOI 10.1056/nejmoa1508054PMC PMC4734119

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The prevalence and spectrum of predisposing mutations among children and adolescents with cancer are largely unknown. Knowledge of such mutations may improve the understanding of tumorigenesis, direct patient care, and enable genetic counseling of patients and families. METHODS: In 1120 patients younger than 20 years of age, we sequenced the whole genomes (in 595 patients), whole exomes (in 456), or both (in 69). We analyzed the DNA sequences of 565 genes, including 60 that have been associated with autosomal dominant cancer-predisposition syndromes, for the presence of germline mutations. The pathogenicity of the mutations was determined by a panel of medical experts with the use of cancer-specific and locus-specific genetic databases, the medical literature, computational predictions, and second hits identified in the tumor genome. The same approach was used to analyze data from 966 persons who did not have known cancer in the 1000 Genomes Project, and a similar approach was used to analyze data from an autism study (from 515 persons with autism and 208 persons without autism). RESULTS: Mutations that were deemed to be pathogenic or probably pathogenic were identified in 95 patients with cancer (8.5%), as compared with 1.1% of the persons in the 1000 Genomes Project and 0.6% of the participants in the autism study. The most commonly mutated genes in the affected patients were TP53 (in 50 patients), APC (in 6), BRCA2 (in 6), NF1 (in 4), PMS2 (in 4), RB1 (in 3), and RUNX1 (in 3). A total of 18 additional patients had protein-truncating mutations in tumor-suppressor genes. Of the 58 patients with a predisposing mutation and available information on family history, 23 (40%) had a family history of cancer. CONCLUSIONS: Germline mutations in cancer-predisposing genes were identified in 8.5% of the children and adolescents with cancer. Family history did not predict the presence of an underlying predisposition syndrome in most patients. (Funded by the American Lebanese Syrian Associated Charities and the National Cancer Institute.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1508054

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Enhancements and modifications of primer design program Primer3
Kõressaar, T., & Remm, M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm091 · Cited by 2,618
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544
Principles and Practice of Pediatric Oncology
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-8-636_3 · Cited by 2,034
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596
Self-citation

Show all 56 references

Research works printed but not linked: 3

Lindor NM, 2008, J Natl Cancer Inst Monogr, 1
Meldrum C, 2011, Clin Biochem Rev, 32, 177
Armes JE, 1999, Cancer Res, 59, 2011

Sorted by citations

Items 601–700 of 1,000

Childhood acute lymphoblastic leukemia survival and spatial analysis of socio-environmental risks in Mexico
Calderón, J., Jarquín‐Yáñez, L., Reyes-Arreguin, L. E., Díaz-Padilla, L. A., Gonzalez-Compean, J. L., González-Montalvo, P. M., Rivera-Gómez, R., Villanueva-Toledo, J. R., Pech, K., Arrieta, O. G., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1236942 · Cited by 9
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics
Koster, R., Schipper, L. J., Giesbertz, N. A. A., van Beek, D. M., Mendeville, M., Samsom, K. G., Rosenberg, E. H., Hogervorst, F. B. L., Roepman, P., Boelens, M. C., et al. (2023) · Genetics in Medicine · doi:10.1016/j.gim.2023.101032 · Cited by 8
Acute myeloid leukemia with rare recurring translocations—an overview of the entities included in the international consensus classification
Rørvik, S. D., Torkildsen, S., Bruserud, Ø., & Tvedt, T. H. A. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05680-5 · Cited by 9
Identification of TP53 germline variants in pediatric patients undergoing tumor testing: strategy and prevalence
Luo, M., Wong, D., Zelley, K., Wu, J., Schubert, J., Denenberg, E. H., Fanning, E. A., Chen, J., Gallo, D., Golenberg, N., et al. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae102 · Cited by 9
Germline analysis of an international cohort of pediatric diffuse midline glioma patients
Mateos, M. K., Ajuyah, P., Fuentes-Bolanos, N., El-Kamand, S., Barahona, P., Alteköester, A.-K., Mayoh, C., Holliday, H., Liu, J., Cui, L., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf061 · Cited by 9
Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study
Postema, F. A. M., Hopman, S. M. J., de Borgie, C. A. J. M., Aalfs, C. M., Anninga, J., Berger, L. P. V., Bleeker, F. E., Dommering, C. J., van Eijkelenburg, N. K. A., Hammond, P., et al. (2021) · Familial Cancer · doi:10.1007/s10689-021-00237-1 · Cited by 9
Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort
Kloth, K., Obrecht, D., Sturm, D., Pietsch, T., Warmuth‐Metz, M., Bison, B., Mynarek, M., & Rutkowski, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.756025 · Cited by 9
How do young people with a hereditary cancer predisposition syndrome understand and experience cancer survivorship? “With Li‐Fraumeni syndrome, it’s just an intermission”
Werner‐Lin, A., Shepherd, R. F., Rising, C. J., Thompson, A. S., Huelsnitz, C. O., Wilsnack, C., Boyd, P., Sleight, A. G., Hutson, S. P., & Khincha, P. P. (2022) · Psycho-Oncology · doi:10.1002/pon.6080 · Cited by 9
CHEK2 Alterations in Pediatric Malignancy: A Single-Institution Experience
Abdelghani, E., Schieffer, K. M., Cottrell, C. E., Audino, A. N., Zajo, K. N., & Shah, N. (2023) · Cancers · doi:10.3390/cancers15061649 · Cited by 9
Radiation Therapy Technology Advances and Mitigation of Subsequent Neoplasms in Childhood Cancer Survivors
Stokkevåg, C. H., Journy, N., Vogelius, I. R., Howell, R. M., Hodgson, D. C., & Bentzen, S. M. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.01.206 · Cited by 9
Congenital neurodevelopmental anomalies in pediatric and young adult cancer
Wong‐Siegel, J. R., Johnson, K. J., Gettinger, K., Cousins, N., McAmis, N. E., Zamarione, A., & Druley, T. E. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38387 · Cited by 9
A pediatric perspective on genomics and prevention in the twenty-first century
Chaudhari, B. P., Manickam, K., & McBride, K. L. (2019) · Pediatric Research · doi:10.1038/s41390-019-0597-z · Cited by 8
Comprehensive assessments of germline deletion structural variants reveal the association between prognostic MUC4 and CEP72 deletions and immune response gene expression in colorectal cancer patients
Lin, P., Chen, H.-O., Lee, C.-J., Yeh, Y., Shen, M., & Chiang, J.-H. (2021) · Human Genomics · doi:10.1186/s40246-020-00302-3 · Cited by 9
Incidental finding of APC deletion in a child: double trouble or double chance? – a case report
Rosina, E., Rinaldi, B., Silipigni, R., Bergamaschi, L., Gattuso, G., Signoroni, S., Guerneri, S., Carnevali, A., Marchisio, P., & Milani, D. (2021) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-021-00969-x · Cited by 9
Cancer predisposition in pediatric neuro-oncology—practical approaches and ethical considerations
Hirsch, S., Dikow, N., Pfister, S. M., & Pajtler, K. W. (2021) · Neuro-Oncology Practice · doi:10.1093/nop/npab031 · Cited by 9
NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
Yoshida, M., Nakabayashi, K., Yang, W., Sato‐Otsubo, A., Tsujimoto, S., Ogata‐Kawata, H., Kawai, T., Ishiwata, K., Sakamoto, M., Okamura, K., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005507 · Cited by 9
Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer
Sylvester, D. E., Chen, Y., Grima, N., Saletta, F., Padhye, B. D., Bennetts, B., Wright, D. C., Krivanek, M., Graf, N. S., Zhou, L., et al. (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23006 · Cited by 9
Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States
Venier, R. E., Grubs, R. E., Kessler, E., Cooper, K. L., Bailey, K. M., & Meade, J. C. (2022) · Journal of Genetic Counseling · doi:10.1002/jgc4.1559 · Cited by 9
Pediatric cancer genetics
Dean, S., & Farmer, M. B. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000543 · Cited by 9
TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia
Junk, S. V., Klein, N., Schreek, S., Zimmermann, M., Möricke, A., Bleckmann, K., Alten, J., Dağdan, E., Cario, G., Kratz, C. P., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.205849 · Cited by 9
Ein Update zum Li-Fraumeni-Syndrom
Dutzmann, C. M., Vogel, J., Kratz, C. P., Pajtler, K. W., Pfister, S. M., & Dörgeloh, B. B. (2019) · Der Pathologe · doi:10.1007/s00292-019-00657-y · Cited by 9
Challenges in Interpreting TP53 Pathogenic Variants With a Low Minor Allele Frequency in Germline Genetic Testing: A Case Report of a Patient With Mosaic Li-Fraumeni Syndrome
Peacock, E. G., Grenon, L. M., Batalini, F., & Tung, N. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00279 · Cited by 10
Smart Manufacturing - When Artificial Intelligence Meets the Internet of Things
Tan, Y. K. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90084 · Cited by 9
Enabling population assignment from cancer genomes with SNP2pop
Huang, Q. D., & Baudis, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-61854-x · Cited by 9
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactionsPreprint
Bolouri, H., Farrar, J. E., Triche, T., Ries, R. E., Lim, E. L., Alonzo, T. A., Ma, Y. P., Moore, R., Mungall, A. J. J., Marra, M. A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/125609 · Cited by 9
Self-citation
Adolescent and Young Adult Understanding of Their Childhood Cancer Predisposition Diagnosis: A Qualitative Study
Sharp, K. M. H., Blake, A., Flynn, J., Brown, S., Rashed, J., Harrison, L. W., McGee, R. B., Mandrell, B. N., & Nichols, K. E. (2023) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2023.113538 · Cited by 8
Self-citation
Prevalence and spectrum of cancer predisposition germline mutations in young patients with the common late‐onset cancers
Hao, S., Zhao, X., Fan, Y., Liu, Z., Zhang, X., Wei, L., Yuan, H., Zhang, J., Zhang, Y., Ma, T., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6445 · Cited by 8
Self-citation
Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia—a case-control study
Junk, S. V., Förster, A., Schmidt, G., Zimmermann, M., Fedders, B., Haermeyer, B., Bergmann, A. K., Möricke, A., Cario, G., Auber, B., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02173-2 · Cited by 8
DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition
Hayes, M. N., Cohen‐Gogo, S., Kee, L., Xiong, X., Weiss, A., Layeghifard, M., Ladumor, Y., Valencia-Sama, I., Rajaselvam, A., Kaplan, D. R., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115537 · Cited by 9
A coordinated multidisciplinary model of care is needed for child and family centered care in pediatric genetic cancer risk services: a scoping review
Grant, A. M., Taylor, N. J., Maguire, J. M., Graves, S. D., Signorelli, C., Fuentes-Bolanos, N., Tucker, K., & Cruickshank, M. (2025) · Familial Cancer · doi:10.1007/s10689-025-00474-8 · Cited by 8
Immunometabolites and cancer: the role of 2-hydroxyglutarate, succinate, fumarate and itaconate in tumour development and anti-tumour immunity
Pfefer, T., Bessenyei, A. H., & O'Neill, L. A. J. (2026) · Immunology Letters · doi:10.1016/j.imlet.2026.107153 · Cited by 8
Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark
Stoltze, U. K., Skytte, A., Roed, H., Hasle, H., Ejlertsen, B., Hansen, T. V. O., Schmiegelow, K., Gerdes, A., & Wadt, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190050 · Cited by 8
Cancer genetic counseling for childhood cancer predisposition is associated with improved levels of knowledge and high satisfaction in parents
Juarez, O. A., Pencheva, B., Bellcross, C. A., Schneider, K. W., Turner, J. T., & Porter, C. C. (2020) · Journal of Genetic Counseling · doi:10.1002/jgc4.1357 · Cited by 9
Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites
Feng, Q., Nickels, E. M., Muskens, I. S., de Smith, A. J., Gauderman, W. J., Yee, A. C., Ricker, C. N., Mack, T. M., Leavitt, A. D., Godley, L. A., et al. (2021) · eLife · doi:10.7554/elife.64793 · Cited by 8
What’s in a Name? Parents’ and Healthcare Professionals’ Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes
Hunter, J. D., Robertson, E. G., Hetherington, K., Ziegler, D. S., Marshall, G. M., Kirk, J., Marron, J. M., Denburg, A., Barlow-Stewart, K. K., Warby, M., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081327 · Cited by 8
Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition
MacFarland, S. P., Maese, L. D., Rednam, S. P., Kamihara, J., Perrino, M. R., Nichols, K. E., Brodeur, G. M., Schiffman, J. D., Plon, S. E., Diller, L., et al. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0215 · Cited by 8
Self-citation
Germline findings in patients with advanced malignancies screened with paired blood–tumour testing for personalised treatment approaches
Roggia, C., Armeanu–Ebinger, S., Gschwind, A., Kelemen, O., Hertler, S., Faust, U., Liebmann, A., Haack, T. B., Neumann, M., Bonzheim, I., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.11.003 · Cited by 8
The role of cancer predisposition syndrome in children and adolescents with very rare tumours
Orbach, D. H., Brecht, I. B., Corradini, N., Bouchoucha, Y. X., Roganović, J., Bourdeaut, F., Réguerre, Y., Kuiper, R. P., Paillerets, B. B., Ferrari, A., et al. (2023) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2023.100023 · Cited by 8
Second malignancy risk among pediatric, adolescent, and young adult survivors of fusion‐positive and fusion‐negative sarcomas: Results from the SEER database, 1992 through 2012
Lupo, P. J., Brown, A. L., & Hettmer, S. (2016) · Cancer · doi:10.1002/cncr.30222 · Cited by 8
Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment
Konnick, E. Q., & Pritchard, C. C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0350-8 · Cited by 8
Pathogenic Mutations in Cancer-Predisposing Genes: A Survey of 300 Patients with Whole-Genome Sequencing and Lifetime Electronic Health Records
He, K., Zhao, Y., McPherson, E. W., Li, Q., Xia, F., Weng, C., Wang, K., & He, M. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167847 · Cited by 8
Epidemiology and Etiology of Childhood ALL
Tulstrup, M., Stoltze, U. K., Schmiegelow, K., & Yang, J. J. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-39708-5_1 · Cited by 8
Multiple pilomatrixomas in a survivor of WNT‐activated medulloblastoma leading to the discovery of a germline APC mutation and the diagnosis of familial adenomatous polyposis
Bendelsmith, C., Skrypek, M. M., Patel, S. R., Pond, D., Linabery, A. M., & Bendel, A. E. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26756 · Cited by 8
Hematologic indices in individuals with pathogenic germline DICER1 variants
Vasta, L. M., Khan, N. E., Higgs, C. P., Harney, L. A., Carr, A. G., Harris, A. K., Schultz, K. A. P., McMaster, M. L., & Stewart, D. R. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002651 · Cited by 9
The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden
de Ståhl, T. D., Shamikh, A., Mayrhofer, M., Juhos, S., Basmaci, E., Prochazka, G., Garcia, M., Somarajan, P. R., Zielinska-Chomej, K., Illies, C., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04178-4 · Cited by 11
Future Prospects of Therapeutic Clinical Trials in Acute Myeloid Leukemia
Khan, M., Mansoor, A., & Kadia, T. M. (2016) · Future Oncology · doi:10.2217/fon-2016-0262 · Cited by 8
Bridging Adult Experience to Pediatrics in Oncology Drug Development
Leong, R., Zhao, H., Reaman, G. H., Liu, Q., Wang, Y., Stewart, C. F., & Burckart, G. J. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.910 · Cited by 8
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent
Powis, Z., Espenschied, C. R., LaDuca, H., Hagman, K. D. F., Paudyal, T., Li, S., Inaba, H., Mauer, A. M., Nathanson, K. L., Knost, J. A., et al. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.04.002 · Cited by 8
Novel PDE10A-BRAF Fusion With Concomitant NF1 Mutation Identified in an Undifferentiated Sarcoma of Infancy With Sustained Response to Trametinib
Vairy, S., Jouan, L., Bilodeau, M., Dormoy-Raclet, V., Gendron, P., Couture, F., Léveillé, F., Tihy, F., Lemyre, E., Soglio, D. B. D., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.18.00007 · Cited by 8
Prevalence of germline predisposition gene mutations in pediatric acute myeloid leukemia: Genetic background of pediatric AML
Jeong, D., Lee, D. S., Kim, N., Choi, S., Kim, K., Kim, S., Im, K., Park, H. S., Yun, J., Lim, K. M., et al. (2019) · Leukemia Research · doi:10.1016/j.leukres.2019.106210 · Cited by 8
Data-driven approaches to advance research and clinical care for pediatric cancer
Gout, A. M., Arunachalam, S., Finkelstein, D., & Zhang, J. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188571 · Cited by 9
Self-citation
Genetic Factors
Walsh, M. F., Cadoo, K. A., Salo‐Mullen, E. E., Dubard-Gault, M. E., Stadler, Z. K., & Offit, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00013-x · Cited by 10
Self-citation
Importance of updating family cancer history in childhood cancer survivors
Russo, S., Warby, M., Tucker, K., Wakefield, C. E., & Cohn, R. J. (2017) · Familial Cancer · doi:10.1007/s10689-017-9988-7 · Cited by 8
Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study
Webster, E., Perez, L. R., Ahsan, M. D., Levi, S. R., Chandler, I. R., Thomas, C., Babagbemi, K., Sharaf, R., & Frey, M. K. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.02.028 · Cited by 8
Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world
Cheo, S. W., Ong, P. Y., Ow, S. G. W., Chan, G. H. J., Tan, D. S. P., Lim, Y. W., Kong, H. L., Wong, A. L. A., Lim, S. E., Walsh, R. J., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103482 · Cited by 7
A content analysis of parents’ reflections on pathogenic and uncertain pediatric oncology germline sequencing results
Sharp, K. M. H., Clark, M. E., Jurbergs, N., Ouma, A. A., Harrison, L. W., Taylor, L. M., Hamilton, K. V., McGee, R. B., Nuccio, R., Hines‐Dowell, S. J., et al. (2024) · Familial Cancer · doi:10.1007/s10689-024-00417-9 · Cited by 7
Self-citation
A practical guide to apply AI in childhood cancer: Data collection and AI model implementation
Wen, S., Theobald, S., Gangas, P., Jiménez, K. C. B., Merks, J. H. M., Schoot, R. A., Meyerheim, M., & Graf, N. M. (2024) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2024.100197 · Cited by 7
Holistic precision wellness: Paving the way for next‐generation precision medicine ( ngPM ) with AI , biomedical informatics, and clinical medicine
Mohammed, S. G. A. A., Qoronfleh, M. W., Acar, A., & Al-Dewik, N. I. E. (2025) · FASEB BioAdvances · doi:10.1096/fba.2024-00198 · Cited by 8
Variant calling from RNA-Seq data reveals allele-specific differential expression of pathogenic cancer variants
Bollas, A. E., Gaither, J. B., Schieffer, K., White, P., & Mardis, E. (2025) · Communications Medicine · doi:10.1038/s43856-025-00901-y · Cited by 7
Self-citation
Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cells
McCastlain, K., Welsh, C. E., Ni, Y., Ding, L., Franco, M., Autry, R. J., Sejdiu, B. I., Chang, T.-C., Chen, W., Wu, H., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt3873 · Cited by 9
Self-citation
Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro- and neuroblastoma
Theruvath, J. L., Russo, A., Kron, B., Paret, C., Wingerter, A., Malki, K. E., Neu, M. A., Alt, F., Staatz, G., Stein, R., et al. (2016) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2016.1184362 · Cited by 7
Clinical and Molecular Features in Medulloblastomas Subtypes in Children in a Cohort in Taiwan
Wu, K.-S., Sung, S., Huang, M., Lin, Y., Chang, C., Fang, C., Wong, T., Chen, H., & Tsai, M. (2022) · Cancers · doi:10.3390/cancers14215419 · Cited by 7
Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15 000 leukemia cases and 46 000 controls from the Childhood Cancer and Leukemia International Consortium
Lupo, P. J., Chambers, T. M., Mueller, B. A., Clavel, J., Dockerty, J. D., Doody, D. R., Erdmann, F., Ezzat, S., Filippini, T., Hansen, J., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34720 · Cited by 7
The Germline Variants rs61757955 and rs34988193 Are Predictive of Survival in Lower Grade Glioma Patients
Chatrath, A., Kiran, M., Kumar, P., Ratan, A., & Dutta, A. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0996 · Cited by 7
Increased risk for other cancers in individuals with Ewing sarcoma and their relatives
Abbott, D., O’Brien, S., Farnham, J. M., Young, E. L., Yap, J. T., Jones, K. B., Lessnick, S. L., Randall, R. L., Schiffman, J. D., & Cannon‐Albright, L. (2019) · Cancer Medicine · doi:10.1002/cam4.2575 · Cited by 7
High prevalence of SMARCB1 constitutional abnormalities including mosaicism in malignant rhabdoid tumors
Shirai, R., Osumi, T., Terashima, K., Kiyotani, C., Uchiyama, M., Tsujimoto, S., Yoshida, M., Yoshida, K., Uchiyama, T., Tomizawa, D., et al. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0614-z · Cited by 7
Frequency of pathogenic/likely pathogenic germline variants in cancer‐related genes among children with acute leukemia in Saudi Arabia
Alsultan, A. S., Essa, M., Al‐Jefri, A., Ayas, M. F., Alharbi, M., Alkhayat, N., Al‐Anzi, F., Yassin, F., Al-Kasim, F., Alharbi, Q. K., et al. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28340 · Cited by 7
Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults
Ji, J., Kaneva, K., Hiemenz, M., Dhall, G., Davidson, T. B., Erdreich‐Epstein, A., Hawes, D., Hurth, K. M., Margol, A., Mathew, A. J., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab037 · Cited by 7
Clinical application of 18F-DOPA PET/TC in pediatric patients.
Masselli, G., Casciani, E., Angelis, C. D., Sollaku, S., & Gualdi, G. (2021) · PubMed Central · Cited by 7
Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms
Braunstein, E. M., Chen, H., Juarez, F., Yang, F., Tao, L. A., Makhlin, I., Williams, D. M., Chaturvedi, S., Pallavajjala, A., Karantanos, T., et al. (2021) · Cancers · doi:10.3390/cancers13133246 · Cited by 7
The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: a retrospective cohort study in a tertiary-care children’s hospital
Huber, S., Schimmel, M., Dunstheimer, D., Nemes, K., Richter, M., Streble, J., Vollert, K., Walden, U., Frühwald, M. C., & Kuhlen, M. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-04347-x · Cited by 7
Factors impacting adolescent and young adult cancer patients’ decision to pursue genetic counseling and testing
Morand, M., Roth, M. E., Peterson, S. K., Bednar, E. M., Ramdaney, A., Livingston, J. A., Yarbrough, A. R., & Corredor, J. L. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-06974-y · Cited by 7
Germline De Novo Mutations as a Cause of Childhood Cancer
Rashed, W. M., Marcotte, E. L., & Spector, L. G. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00505 · Cited by 8
Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement
Miller, K. E., Wheeler, G. L., LaHaye, S., Schieffer, K. M., Cearlock, S., Venkata, L. P. R., Otero-Bravo, A., Grischow, O. E., Kelly, B., White, P., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.932337 · Cited by 7
Self-citation
Harnessing immunomodulation during DNA damage in Ewing sarcoma
Daley, J. D., Olson, A. C., & Bailey, K. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1048705 · Cited by 8
Thyroid Cancer, Neuroendocrine Tumor, Adrenal Adenoma, and Other Tumors in a Patient With a Germline PMS1 Mutation
Alghamdi, B., Al‐Hindi, H., Murugan, A. K., & Alzahrani, A. S. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad035 · Cited by 7
Research on Rare Diseases in Germany - Cancer Predisposition Syndrome Registry
Dutzmann, C. M., Palmaers, N. E., Müntnich, L. J., Strüwe, F. J., Penkert, J., Sänger, B., Hoffmann, B., Karow, A., Reimer, C., Gerasimov, T., et al. (2023) · PubMed Central · doi:10.25646/11828 · Cited by 7
El nuevo reto en oncología: la secuenciación NGS y su aplicación a la medicina de precisión
Calabria, I., Pedrola, L., Berlanga, P., Aparisi, M. J., Sánchez-Izquierdo, D., Cañete, A., Cervera, J., Millán, J. M., & Castel, V. (2016) · Anales de Pediatría · doi:10.1016/j.anpedi.2016.05.006 · Cited by 7
Long Noncoding RNA PRRG4-4 Promotes Viability, Cell Cycle, Migration, and Invasion in Lung Cancer Cells
Wang, Y., Gong, W. J., Zhou, S.-Y., Yang, L., Qiu, F., Lin, M., Su, W., Nie, W., Datta, S., Rao, B., et al. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4220 · Cited by 7
Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes
Artomov, M., Vijai, J., Tiao, G., Thomas, T., Schrader, K. A., Klein, R. J., Kieżun, A., Gupta, N., Margolin, L., Stratigos, A., et al. (2019) · European Journal of Human Genetics · doi:10.1038/s41431-019-0346-0 · Cited by 7
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial
Bernardi, S., Farina, M., Zanaglio, C., Cattina, F., Polverelli, N., Schieppati, F., Re, F., Foroni, C., Malagola, M., Dunbar, A. J., et al. (2020) · Case Reports in Hematology · doi:10.1155/2020/2795656 · Cited by 7
A Rapid and Simple Bead-Bashing-Based Method for Genomic DNA Extraction from Mammalian Tissue
Wei, S., Levy, B., Hoffman, N., Cujar, C. P., Rodney-Sandy, R., Wapner, R. J., D’Alton, M. E., & Williams, Z. (2020) · BioTechniques · doi:10.2144/btn-2019-0172 · Cited by 8
Developmental Mutators and Early Onset Cancer
Kentsis, A., & Frank, S. A. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00189 · Cited by 6
Case Report of a Local Recurrence of Spindle Cell Embryonal Rhabdomyosarcoma
Mulita, F., Parchas, N., Germanos, S., Papadoulas, S., & Maroulis, I. C. (2020) · Medical Archives · doi:10.5455/medarh.2020.74.240-242 · Cited by 7
Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma
van Engelen, N., van Dijk, F., Waanders, E., Buijs, A., Vermeulen, M. A., Loeffen, J. L. C., Kuiper, R. P., & Jongmans, M. C. J. (2021) · Familial Cancer · doi:10.1007/s10689-021-00244-2 · Cited by 7
Pediatric brain tumors as a developmental disease
Bruschi, M., Grill, J., & Guerrini‐Rousseau, L. (2021) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000782 · Cited by 8
Predisposición genética al cáncer infantil
Salas, P. C., Lapunzina, P. D., & Pérez‐Martínez, A. (2017) · Anales de Pediatría · doi:10.1016/j.anpedi.2017.01.011 · Cited by 7
Genomic testing for germline predisposition to hematologic malignancies
Hwang, S. M. (2024) · Blood Research · doi:10.1007/s44313-024-00012-y · Cited by 6
Genetic and clinical characteristics of genetic tumor syndromes in the central nervous system cancers: Implications for clinical practice
Wang, X., Chen, J., Wang, Y., Luo, N., Han, T., Yin, X., Song, X., Chen, D., & Gong, J. (2024) · iScience · doi:10.1016/j.isci.2024.111073 · Cited by 6
SMARCAL1 is a new osteosarcoma predisposition gene
Rafati, M., Guenther, L. M., Egolf, L. E., Gianferante, D. M., Kim, J., Wang, K., Zhu, B., Spector, L. G., Anderson, N., Janeway, K. A., et al. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf278 · Cited by 8
Genomic Characterization of a Metastatic Alveolar Rhabdomyosarcoma Case Using FISH Studies and CGH+SNP Microarray Revealing FOXO1-PAX7 Rearrangement with MYCN and MDM2 Amplification and RB1 Region Loss
Karunamurthy, A. D., Hoffner, L., Hu, J., Shaw, P. H., Ranganathan, S., Yatsenko, S. A., & Surti, U. (2016) · Cytogenetic and Genome Research · doi:10.1159/000458167 · Cited by 6
Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients
Satake, T., Kondo, S., Tanabe, N., Mizuno, T., Katsuya, Y., Sato, J., Koyama, T., Yoshida, T., Hirata, M., & Yamamoto, N. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0018 · Cited by 6
Comparing the Diagnostic Yield of Germline Exome Versus Panel Sequencing in the Diverse Population of the Texas KidsCanSeq Pediatric Cancer Study
Desrosiers, L., Wang, T., Reuther, J., Miles, G., Dai, H., Jo, E., Russell, H. V., Raesz-Martinez, R., Recinos, A. M., Gutierrez, S., et al. (2024) · JCO Precision Oncology · doi:10.1200/po.24.00187 · Cited by 6
Utility of genomic testing in children, adolescents, and young adults with cancer
DeBortoli, E., McGahan, E., Yanes, T., Berkman, J. L., Fuentes-Bolanos, N., Milch, V., Steinberg, J., & McInerney-Leo, A. M. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae233 · Cited by 8
The childhood cancer data initiative: enabling data sharing to drive research advances and transform pediatric cancer diagnosis and treatment
Jagu, S., Auvil, J. M. G., & Reaman, G. H. (2024) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001422 · Cited by 6
In vitro cytotoxicity, gene expression, bioinformatics, biochemical analysis, and in silico analysis of synthesized carbonitrile derivatives
Tüzün, B., Ağbektaş, T., Naghiyev, F. N., Taş, A., Zontul, C., Özüm, Ü., Khalilov, A. N., Siliğ, Y., Çakmak, N. K., & Mamedov, I. G. (2025) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-025-03315-7 · Cited by 6
Improvement of outcomes for TP53 carriers
Plon, S. E. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30382-5 · Cited by 6
Seltene Tumoren als Leitsymptom hereditärer Tumorsyndrome
Perne, C., Steinke‐Lange, V., Aretz, S., & Spier, I. (2020) · Der Pathologe · doi:10.1007/s00292-020-00806-8 · Cited by 6
Stratégie diagnostique des sarcomes des tissus mous de l’enfant et adolescent
Collignon, C., Brisse, H. J., Lemelle, L., Cardoen, L., Gauthier, A., Pierron, G., Roussel, A. M., Dumont, B., Alimi, A., Cordero, C., et al. (2020) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.06.008 · Cited by 6
Improving Detection of Cancer Predisposition Syndromes in Pediatric Oncology
Knoll, J., Li, A., Smith, C. H., Schratz, K. E., Cooper, S., Meah, T., Helmke, E., Pratilas, C. A., & Bodurtha, J. N. (2020) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000001987 · Cited by 6

Authors: Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., Wilkinson, M. R., Vadodaria, B., Chen, X., McGee, R. B., Hines-Dowell, S., Nuccio, R., Quinn, E., Shurtleff, S. A., Rusch, M., Patel, A., Becksfort, J. B., Wang, S., Weaver, M. S., Ding, L., Mardis, E. R., Wilson, R. K., Gajjar, A., Ellison, D. W., Pappo, A. S., Pui, C.-H., Nichols, K. E., & Downing, J. R.
Affiliations: St. Jude Children's Research Hospital (US)
Washington University in St. Louis (US)
ORCID: Zhang, Jinghui
Walsh, Michael F.
Wu, Gang
Edmonson, Michael N.
Gruber, Tanja A.
Easton, John
Ma, Xiaotu
Zhou, Xin
Yergeau, Donald A.
Wilkinson, Mark R.
Chen, Xiang
McGee, Rose B.
Nuccio, Regina
Quinn, Emily
Rusch, Michael
Patel, Aman
Becksfort, Jared B.
Weaver, Meaghann S.
Ding, Li
Mardis, Elaine R.
Wilson, Richard K.
Gajjar, Amar
Ellison, David W.
Pappo, Alberto S.
Pui, Ching-Hon
Nichols, Kim E.
Downing, James R.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2015-12-10
Volume: 373
Issue: 24
Pages: 2336-2346
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1508054
PMC: PMC4734119
OpenAlex: W2303408208
Cited by: 1,345
References: 56
Citations by year: 2026: 90 · 2025: 113 · 2024: 151 · 2023: 132 · 2022: 134 · 2021: 161 · 2020: 141 · 2019: 122 · 2018: 113 · 2017: 101 · 2016: 76 · 2015: 5
FWCI: 67.59
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Cancer Institute (R01CA180006, CA21765, P30CA021765)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: germline mutations, cancer susceptibility genes, childhood cancer, children and adolescents, TP53, APC, BRCA2, neurofibromatosis type 1, PMS2, RB1, RUNX1, tumor suppressor, pathogenicity assessment, family history of cancer, genetic counseling, autism spectrum disorder
MeSH terms: Adolescent, Autistic Disorder, Child, Female, Genes, Dominant, Humans, Male, Neoplasms, Genome, Human, Sequence Analysis, DNA, Germ-Line Mutation, SEER Program, Genetic Predisposition to Disease, Genes, Neoplasm, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Germline Mutations in Predisposition Genes in Pediatric Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks